1 – 10 of 11
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Anti-Ro52 positivity is associated with progressive interstitial lung disease in systemic sclerosis-an exploratory study
(
- Contribution to journal › Article
- 2021
-
Mark
Bioengineering Approaches for the Distal Lung
(
- Chapter in Book/Report/Conference proceeding › Book chapter
- 2019
-
Mark
Tissue remodelling in pulmonary fibrosis linked to 5-HT2 receptor activation
(
- Thesis › Doctoral thesis (compilation)
- 2017
-
Mark
Mapping and predicting mortality from systemic sclerosis
(
- Contribution to journal › Article
-
Mark
The arachidonate 5-lipoxygenase activating protein gene polymorphism is associated with the risk of scleroderma-related interstitial lung disease : A multicentre European Scleroderma Trials and Research group (EUSTAR) study
(
- Contribution to journal › Article
- 2016
-
Mark
5-HT2B receptor antagonists attenuate myofibroblast differentiation and subsequent fibrotic responses in vitro and in vivo
(
- Contribution to journal › Article
- 2011
-
Mark
Activated MCTC mast cells infiltrate diseased lung areas in cystic fibrosis and idiopathic pulmonary fibrosis
(
- Contribution to journal › Article
- 2007
-
Mark
BAL fluid derived fibroblasts differ from biopsy derived fibroblasts in systemic sclerosis.
(
- Contribution to journal › Article
- 2005
-
Mark
Airway mechanics of mice and men
(
- Thesis › Doctoral thesis (compilation)
- 2002
-
Mark
Proteoglycan and proteome profiling of central human pulmonary fibrotic tissue utilizing miniaturized sample preparation : a feasibility study
(
- Contribution to journal › Article